379 results on '"Gabriele Cruciani"'
Search Results
302. 3D QSAR on Mutagenic Heterocyclic Amines That are Substrates of Cytochrome P450 1A2
303. Handling Information from 3D Grid Maps for QSAR Studies
304. Structural Requirements for Binding to Cannabinoid Receptors
305. Series Design in Synthetic Chemistry
306. Molecular Field-Derived Descriptors for the Multivariate Modeling of Pharmacokinetic Data
307. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds
308. Molecular lipophilicity descriptors: a multivariate analysis
309. Antileishmanial Chalcones: Statistical Design, Synthesis, andThree-Dimensional Quantitative Structure-Activity Relationship Analysis
310. Synthesis and antibacterial evaluation of [1,3]benzothiazino[3,2-a]quinoline- and [3,1]benzothiazino[1,2-a]quinoline-6-carboxylic acid derivatives
311. Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors
312. Smart Region Definition: A New Way To Improve the Predictive Ability and Interpretability of Three-Dimensional Quantitative Structure-Activity Relationships
313. The Role of Water in Receptor-Ligand Interactions. A 3D-QSAR Approach
314. A novel strategy for improving ligand selectivity in receptor-based drug design
315. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection
316. 6-Aminoquinolones: a New Class of Quinolone Antibacterials?
317. Comparative Molecular Field Analysis Using GRID Force-Field and GOLPE Variable Selection Methods in a Study of Inhibitors of Glycogen Phosphorylase b
318. GOLPE: An advanced chemometric tool for 3D QSAR problems
319. D-optimal designs in QSAR
320. Use of advanced chemometric tools and comparison of different 3D descriptors in QSAR analysis of prazosin analog α,1-adrenergic antagonists
321. Application of chemometrics to the screening of hazardous chemicals. A case study
322. A Pipeline To Enhance Ligand Virtual Screening: Integrating MolecularDynamics and Fingerprints for Ligand and Proteins.
323. A Broad Anti-influenzaHybrid Small Molecule ThatPotently Disrupts the Interaction of Polymerase Acidic Protein–BasicProtein 1 (PA-PB1) Subunits.
324. The antibacterial activity of quinolones against E.coli: a chemometric study
325. Molecular Interaction Fields : Applications in Drug Discovery and ADME Prediction
326. Response surface models for the formation of PCDD and PCDF in a pilot plant combustion of MSW
327. Comparison of chemometric models for QSAR
328. A comparative chemometric study of QSAR descriptors
329. Chemometric approach to a QSAR study of peptides behaving as NK-2 receptor antagonists
330. Food quality optimization
331. Reliability of CoMFA Models: Effects of Data Scaling and Variable Selection using a Set of Human Synovial Fluid Phospholipase A2 InhibitorsPrediction of Drug Binding Affinities by Comparative Binding Energy Analysis
332. A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields.
333. Discovery of Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus.
334. Molecular Interaction Fields and 3D-QSAR Studies of p53âMDM2 Inhibitors Suggest Additional Features of LigandâTarget Interaction.
335. High-Throughput Virtual Screening of Proteins Using GRID Molecular Interaction Fields.
336. Tautomer Enumeration and Stability Prediction for Virtual Screening on Large Chemical Databases.
337. Targeting the Conformational Transitions of MDM2 and MDMX: Insights into Dissimilarities and Similarities of p53 Recognition.
338. Discovery of Novel and Cardioselective Diltiazem-like Calcium Channel Blockers via Virtual Screening.
339. A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application.
340. Principal Properties for Aromatic Substituents. A Multivariate Approach for Design in QSAR
341. PLS response surface optimization: The CARSO procedure
342. Some applications of the partial least-squares method
343. QSARs and pesticides design
344. QUALITATIVE ORGANIC-ANALYSIS .3. IDENTIFICATION OF DRUGS AND THEIR METABOLITES BY PCA OF STANDARDIZED TLC DATA
345. BioGPS: Navigating biological space to predict polypharmacology, off-targeting, and selectivity
346. Integrating crystallography into early metabolism studies
347. Response surfaces for modelling biological activities by principal properties of substituents: the CARSO procedure
348. GOLPE-Guided Region Selection
349. In silico pK(a) Prediction and ADME Profiling
350. Novel apoptosis inducers in the acute lymphatic leukemia cell line JM
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.